📰 Immune Sciences News
Page 8 - Immune Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immune Sciences. Real-time updates on events, politics, business and more.
November 29, 2023
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw strong trading volume on Wednesday . 620,360 shares traded hands during mid-day trading, an increase of 129% from the previous session’s volume of 271,139 shares.The stock last traded at $15.96 and had previously closed at $15.07. Analyst Upgrades and Downgrades A number of […]
November 20, 2023
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company...
November 19, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) – Analysts at Wedbush upped their FY2023 earnings per share estimates for shares of Alpine Immune Sciences in a research report issued on Wednesday, November 15th. Wedbush analyst R. Driscoll now forecasts that the biotechnology company will earn ($0.96) per share for the year, up from their […]
November 7, 2023
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
November 7, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
November 4, 2023
Preliminary data from the open-label RUBY-3 trial were presented at the American Society of Nephrology Kidney Week 2023.
November 3, 2023
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company presented new...
November 2, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Thursday. Here are some big stocks recording gains in today’s session.
November 2, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
November 1, 2023
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have been given a consensus recommendation of “Buy” by the seven research firms that are covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the […]